Skip to main content

John Fair

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About John Fair

John Fair was last confirmed as Board Member at Dare Bioscience, Inc. (DARE) in a filing dated April 27, 2023. Dare Bioscience, Inc. reported in an 8-K filed January 26, 2024 that John Fair resigned as Chief Commercial Officer, effective June 30, 2024. The proxy statement of Dare Bioscience, Inc. reports total compensation of $755,191 for John Fair in fiscal 2023, including a base salary of $386,000. Disclosed compensation is on record for 4 fiscal years. John Fair has spoken on 7 earnings calls across 1 company, most recently for Dare Bioscience, Inc. on November 9, 2023.

“On January 24, 2024, John Fair, our Chief Commercial Officer, informed us that, in light of the full-scale commercial launch of XACIATO^TM^—bringing to fruition one of his primary responsibilities as Chief Commercial Officer—he will be resigning from all positions with us and his employment with us will end effective June 30, 2024.”
Dare Bioscience, Inc. Form 8-K, filed January 26, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Dare Bioscience, Inc. (DARE) $386,000 $755,191
2022 Dare Bioscience, Inc. (DARE) $365,000 $775,640
2021 Dare Bioscience, Inc. (DARE) $324,038 $813,357
2020 Dare Bioscience, Inc. (DARE) $294,580 $460,955

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.